Predictions
Astrazeneca ADR
Start price
Target price
Perf. (%)
€50.60
27.11.21
27.11.21
€60.00
27.11.22
27.11.22
26.48%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
GSK plc ADR
Start price
Target price
Perf. (%)
€46.25
24.11.21
24.11.21
-
24.11.25
24.11.25
4.32%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.88
16.11.21
16.11.21
-
16.11.22
16.11.22
-2.06%
27.11.21
27.11.21
Amarin Corp. ADR
Start price
Target price
Perf. (%)
€3.40
15.11.21
15.11.21
€2.00
31.12.23
31.12.23
-15.88%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.10
11.11.21
11.11.21
-
11.11.22
11.11.22
-3.41%
15.11.21
15.11.21
Risky Investment
4d Pharma plc
Start price
Target price
Perf. (%)
€0.80
17.10.21
17.10.21
€0.60
17.10.22
17.10.22
-15.63%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
GSK plc ADR
Start price
Target price
Perf. (%)
€41.25
15.09.21
15.09.21
€43.75
15.09.22
15.09.22
-16.61%
15.08.22
15.08.22
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.48
14.09.21
14.09.21
-
14.09.22
14.09.22
-4.46%
19.09.21
19.09.21
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.30
13.09.21
13.09.21
-
13.09.22
13.09.22
-19.25%
19.09.21
19.09.21
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.30
07.09.21
07.09.21
-
07.09.22
07.09.22
-19.25%
18.09.21
18.09.21
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.70
21.08.21
21.08.21
-
21.08.22
21.08.22
14.59%
04.09.21
04.09.21
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€19.40
12.07.21
12.07.21
-
12.07.22
12.07.22
-8.25%
26.07.21
26.07.21
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.42
08.07.21
08.07.21
-
08.07.22
08.07.22
-55.26%
21.05.22
21.05.22
AstraZeneca plc
Start price
Target price
Perf. (%)
€91.61
03.06.21
03.06.21
€115.00
03.06.22
03.06.22
34.21%
04.06.22
04.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected